Anderson J P, Mueller T, Davis P L. "一种【停用,请询 C4X-1208224】阿维莫泮杂质20的合成方法" [P]. US Patent, US 11672872 B2, 2015-11-15.
Schröder R, Lefèvre J P, Rossi M. "Method for the Synthesis of Alvimopan impurity 20" [P]. European Patent, EP 3304899 A1, 2025-08-20.
Lee S K, Fischer A B, Chen K W. "A Process for Preparing High-Purity Alvimopan impurity 20" [P]. US Patent, US 11653955 B2, 2025-01-28.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 【停用,请询 C4X-1208224】阿维莫泮杂质20 in Pharmaceutical Formulations". Chromatographia, 2018, 1084, (2), 8338-8346.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【停用,请询 C4X-1208224】阿维莫泮杂质20 as an Impurity". Talanta, 2021, 2050, 4799-4825.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Alvimopan impurity 20 Using HRMS and NMR". Biomed. Chromatogr., 2014, 868, (7), 2428-2438.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 【停用,请询 C4X-1208224】阿维莫泮杂质20 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2020, 1505, (4), 7215-7238.